317 Model Based Integrated Design of Pharmaceutical Drug Substance and Drug Product and Processes II

Description:
Model Based Integrated Design of Pharmaceutical Drug Substance and Drug Product and Processes II

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum

Chair:
Salvador García-Muñoz
Email: Salvador.Garcia-Munoz@pfizer.com

Co-Chair:
Jeremy Merritt
Email: MERRITT_JEREMY_MILES@LILLY.COM


Papers:

12:30 PM
(317a) Modelling the Manufacturing Process and Product Performance of Roller Compacted Pharmaceutical Tablets
Emmanuela Gavi, Gavin K. Reynolds, Mark A. Pinto and Sean K. Bermingham

12:55 PM
(317b) Modeling Drug Precipitation in the Human Gastrointestinal Tract Using gCOAS
Kaoutar Abbou Oucherif, Jennifer Lu, Sean K. Bermingham, Dan Braido, Filipe Calado, Lynne Taylor and James D. Litster

1:20 PM
(317c) A Molecular Design Approach for Drug Tablet Formulation and Impact On Personalized Medicine
Naresh Pavurala and Luke Achenie

1:45 PM
(317d) An Optimization-Based Strategy to Handle Missing Data in Partial Least Squares
Eranda Harinath, Salvador García-Muñoz and Lorenz T. Biegler

2:10 PM
(317e) Quantitative Structure Retention Relationship (QSRR) Models in An Analytical Quality By Design Framework: Simultaneously Accounting for Compound Properties, Mobile Phase Conditions and Stationary Phase Properties
Koji Muteki, James. E Morgado, George L. Reid, Jian Wang, Gang Xue, Frank Riley, Jeffrey. W Harwood, David. T Fortin and Ian. J Miller

2:35 PM
(317f) Case Study: Model-Based Chromatography Process Development
Stephen Hunt, Robert Todd, Tom Belval, Kevin Tolley and Trent Larsen
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>